The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Editorial

Saturday, 08 June 2013
In-house D-dimer testing and the Wells Score combined meant that cases were referred to secondary care only when patients were strongly suspected to have VTE or pulmonary embolism. Some 86% of VTE cases had properly documented risk assessment.
Category: Editorial
Saturday, 08 June 2013
"The hardest conviction to get into the mind of a beginner is that the education upon which he is engaged is not a medical course but a life course, for which the work of a few years under teachers is but a preparation."Sir William Osler (1849-1919), from The Student of Medicine.
Category: Editorial
Saturday, 08 June 2013
The 2012 ESC guidelines on heart failure, published only two years after the updated NICE guideline, spell out therapeutic advances about which doctors need to be aware. They include recommendations on mineralocorticoid receptor antagonists (MRAs), ivabradine and cardiac resynchronisation therapy (CRT).
Category: Editorial
Saturday, 08 June 2013
For most people symptoms can be controlled by optimal medical management and healthy lifestyle choices. Revascularisation gives symptom relief but is not without risk, and its long-term benefits remain uncertain.
Category: Editorial
Saturday, 08 June 2013
Drugs don't work in people who don't take them. This is a problem that affects 57% of all patients prescribed drugs to prevent heart attacks and strokes, according to a recent meta-analysis combining data from more than 370,000 patients.
Category: Editorial
Saturday, 08 June 2013
Heart rate appears to be a marker for optimal medical therapy in heart failure, and a key determinant of hospitalisation. This study compared practices using the local enhanced service (LES) for heart failure against those not delivering the LES. Education and heart rate control seem to influence hospitalisation rates.
Category: Editorial
Saturday, 08 June 2013
This article traces the history and development of glucagon-like peptide (GLP) mimetics, and their current clinical usage. They give optimal control of HbA1c, which protects against microvascular and macrovascular complications of diabetes. In addition, they are associated with minimal chance of hypoglycaemia, which is now believed to be more dangerous than previously thought.
Category: Editorial
Saturday, 08 June 2013
Abnormal glucose metabolism in people admitted to hospital experiencing an acute coronary syndrome (ACS) strongly predicts development of type 2 diabetes and future cardiovascular events. This paper describes a prospective nine-month parallel design randomised intervention trial involving people admitted to the Wellington Regional Heart and Lung Unit with ACS and hyperglycaemia.
Category: Editorial

Article search and filter